GITR, which is expressed at high levels in activated T cells and Treg (29), was used to identify CD4+CD25low/−GITR+ cells that expand in SLE patients with inactive disease that exert a high inhibitory activity (30). This evidence concerns the gene TNFRSF18 and systemic lupus erythematosus.